Frank Su is the founder of TCR Cure. TCR Cure has raised $47M in total funding. Latest round: Series C. Based in Hong Kong SAR.
Frank Su is the CEO and Co-founder of TCR Cure. He is a veteran entrepreneur and biotech investor with extensive experience in clinical development and business development. TCR Cure specializes in cellular immunotherapy, aiming to become a global leader in the field.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide